ResearcherLanzhou University Second HospitalActive in the last 2 years
Yuman Dong
Matched on ORCID iD 0000-0003-2342-5338; OpenAlex author ID A5048015635. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2024: 1 paper · 2025: 3 papers · 2026: 1 paper
Papers 5
- USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-1228↗
- Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2025.02.021↗
- A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic cancer therapy efficiency. Co-author DOI 10.1016/j.mtbio.2025.101463↗
- KRAS G12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC. Co-author DOI 10.1016/j.xcrm.2025.101966↗
- Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer by inhibition of glutamine metabolism. Co-author DOI 10.1016/j.colsurfb.2024.114162↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zuoyi Jiao · 4 shared papers, 2024–2026 · strength 0.88
- Paper Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer … DOI 10.1016/j.colsurfb.2024.114162↗
- Paper A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic ca… DOI 10.1016/j.mtbio.2025.101463↗
- Paper USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Ca… DOI 10.1158/0008-5472.can-25-1228↗
- Jieru Li · 3 shared papers, 2024–2025 · strength 0.75
- Paper Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer. DOI 10.1016/j.jconrel.2025.02.021↗
- Paper Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer … DOI 10.1016/j.colsurfb.2024.114162↗
- Paper A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic ca… DOI 10.1016/j.mtbio.2025.101463↗
- Yiwei Dai · 3 shared papers, 2024–2025 · strength 0.75
- Paper Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer. DOI 10.1016/j.jconrel.2025.02.021↗
- Paper Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer … DOI 10.1016/j.colsurfb.2024.114162↗
- Paper A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic ca… DOI 10.1016/j.mtbio.2025.101463↗
- Xiangyan Jiang · 3 shared papers, 2025–2026 · strength 0.63
- Paper A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic ca… DOI 10.1016/j.mtbio.2025.101463↗
- Paper USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Ca… DOI 10.1158/0008-5472.can-25-1228↗
- Paper KRAS G12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for … DOI 10.1016/j.xcrm.2025.101966↗
- Zuoyi Jiao · 1 shared paper, 2025 · strength 0.28
- Yong Ma · 1 shared paper, 2026 · strength 0.22
- Tao Wang · 1 shared paper, 2025 · strength 0.18
- Zeyuan Yu · 1 shared paper, 2025 · strength 0.18
- Junhong Guan · 1 shared paper, 2025 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.